why am i gaining weight on glp 1 GLP-1 Medications for Loss: How to Get Started | News The promise and peril of

During the week of June 15, 2026, FDA issued 25 warning letters to telehealth companies over alleged false or misleading promotional claims about compounded GLP-1 productsclaims the agency views as violating the Federal Food, Drug, and Cosmetic Acts (FDCA) misbranding provisions, including Sections 502(a) and 502(n)

evaluate high risk populations and monitor serum liver tests (5.1) Birth defects, decreased IQ, and neurodevelopmental disorders following in uteroexposure

and Chachisvilis, M

Currently approved GLP-1 treatments in the UK include injectable semaglutide (Wegovy) and liraglutide (Saxenda), available through specialist NHS services

Various experimental and epidemiological studies have shown that the consumption of flavonoid-rich foods is associated with a reduced risk of CVDs (227)

However, some patients may not achieve dramatic results, particularly if they miss doses or discontinue treatment prematurely